Darius Adamczyk - 15 Feb 2022 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
Director
Signature
Raavi Deol, as attorney-in-fact for Darius Adamczyk
Issuer symbol
JNJ
Transactions as of
15 Feb 2022
Transactions value $
$0
Form type
4
Date filed
25 Feb 2022, 15:36
Previous filing
16 Feb 2022
Next filing
01 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Deferred Share Units Award $0 +1.03K $0.00 1.03K 15 Feb 2022 Common Stock 1.03K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).